Dr. Nilofer Saba Azad MD
Oncologist | Medical Oncology
1650 Orleans St Bunting-Blaustein Bu Baltimore MD, 21231About
Dr. Azad is an assistant professor of oncology at the Kimmel Cancer Center, with board certifications in medical oncology and internal medicine. She is developing a Phase I/II drug program for the GI ...
Education and Training
Sind Med Coll, Univ Of Karachi, Karachi, Pakistan MD
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The ongoing evolution of proteomics in malignancy.
- CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
- The utility of molecular testing in colorectal cancer: the promise needs progress.
- Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
- A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis.
- Epigenetic therapy for solid tumors: from bench science to clinical trials.
- A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine.
- A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian
- The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Clinical Trials
- A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
- Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
- Phase I Study of SGI-110 With Irinotecan Followed by Randomized Phase II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Previously Treated Metastatic Colorectal Cancer
- A Phase II Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine, Abraxane, Gemcitabine)
- Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma
- Study of ASTX029 in Subjects With Advanced Solid Tumors
Treatments
- Anal Cancer, Bile Duct Cancer, Clinical Trials And More
Dr. Nilofer Saba Azad MD's Practice location
Dr. Nilofer Saba Azad MD's reviews
Write ReviewPatient Experience with Dr. Azad
Recommended Articles
- What Is Stage 4 Bladder Cancer?
Stage 4 bladder cancer is a bladder cancer that has spread through the bladder wall. In this stage, cancer has also invaded the lymph nodes, abdominal wall, and other body organs. This type of cancer is also known as "metastatic" bladder cancer.Stage 4 bladder cancer applies to bladder cancer that...
- Investigating Lumps in Your Breasts
If you have felt a new breast lump that is the same or increasing in size gradually, it is always wise to show this to your health care professional. They will then do a series of tests to investigate if you have a benign lump or breast cancer. Diagnosing and treating early will give you a better...
- Is Ovarian Cancer Hereditary?
All women in the world are at some risk of getting ovarian cancer. Some of them are at greater risk because there are many risk factors, including the family history factor, which can cause the disease to be passed from one female family member to another. If a mother is diagnosed with ovarian...
- Christina Applegate Reveals She Underwent Oophorectomy to Prevent Ovarian Cancer
When a celebrity experiences something, whether a rocky relationship or the birth of a new child, the general public is often thrilled because these occurrences make celebrities seem more relatable. There might not be anything more relatable to a celebrity’s humanness than the announcement of a...
- Exposure to DDT Increases the Risk of Testicular Cancer
Men exposed to the remnants of DDT, a once popular pesticide, have an increased risk of testicular cancer, according to a study published in Journal of the National Cancer Institute. The study shows that men who have high levels of DDT by-product, dichlorodiphenyldichloroethylene (DDE), have a 1.7...
- Ovarian Cancer: Get the Facts
Ovarian cancer is one of the deadliest types of cancer that affects the female population. The disease is very painful and uncomfortable, which can spread to the nearest organs in a very short time. If the disease is discovered at the first (localized) stage, the patient will have a 5-year survival...
Nearby Providers
- Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231
- Dr. Kit Lu M.D.4940 Eastern Ave Baltimore MD 21224
- Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231
- Dr. Michael Streiff M.D.1800 Orleans St Baltimore MD 21287
- Dr. Evan Jacob Lipson MD1650 Orleans St Baltimore MD 21287
- Dr. Douglas Gladstone M.D.1650 Orleans St Baltimore MD 21287